EarningsQ4 2024 Earnings Report

Nektar Therapeutics (NKTR) Q4 2024 Earnings Report

0 Followers

MX:NKTR Q4 2024 EPS Results

Actual EPS$8.10

Consensus EPS-$36.62

Beat/MissBeat by +$44.72

One Year Ago EPS-$59.42

Actual Revenue$525.29M

Expected Revenue$639.13M

Beat/MissMissed by -$113.84M

YoY Revenue Growth+22.15%

QuarterQ4 2024

Date03/12/2025

TimeAfter Close

Conference CallWednesday, March 12, 2025

MX:NKTR Upcoming Earnings

Nektar Therapeutics's next earnings date is estimated for November 5, 2026, based on past reporting schedules.

MX:NKTR Q4 2024 Earnings Call

0:00 / 0:00

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 05, 2026	2026 (Q3)	-37.79 / -	-33.669	―
Aug 13, 2026	2026 (Q2)	-35.49 / -22.15	-53.114	58.31% (+30.97)
May 07, 2026	2026 (Q1)	-28.48 / -32.77	-64.817	49.44% (+32.05)
Mar 12, 2026	2025 (Q4)	-44.54 / -32.05	8.102	-495.56% (-40.15)
Nov 06, 2025	2025 (Q3)	-48.34 / -33.67	-48.613	30.74% (+14.94)
Aug 07, 2025	2025 (Q2)	-54.52 / -53.11	-67.518	21.33% (+14.40)
May 08, 2025	2025 (Q1)	-46.16 / -64.82	-51.313	-26.32% (-13.50)
Mar 12, 2025	2024 (Q4)	-36.62 / 8.10	-59.416	113.64% (+67.52)
Nov 07, 2024	2024 (Q3)	-53.74 / -48.61	-64.817	25.00% (+16.20)
Aug 08, 2024	2024 (Q2)	-49.96 / -67.52	-72.919	7.41% (+5.40)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed